These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 6686689)
1. GABA and feeding: reversal of overeating by central GABA-transaminase inhibition. Coscina DV Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):463-7. PubMed ID: 6686689 [TBL] [Abstract][Full Text] [Related]
2. Anorectic potency of inhibiting GABA transaminase in brain: studies of hypothalamic, dietary and genetic obesities. Coscina DV; Nobrega JN Int J Obes; 1984; 8 Suppl 1():191-200. PubMed ID: 6534893 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of acute feeding responses to systemic 2-deoxyglucose or insulin in rats pretreated with the GABA-transaminase blocker ethanolamine-O-sulfate (EOS). Nobrega JN; Coscina DV Pharmacol Biochem Behav; 1982 Dec; 17(6):1145-8. PubMed ID: 6761711 [TBL] [Abstract][Full Text] [Related]
4. Central injections of the GABA-transaminase inhibitor ethanolamine-O-sulfate (EOS): effects on brain [14C]2-deoxy-D-glucose uptake and behavior in rats. Nobrega JN; Coscina DV Brain Res; 1983 Mar; 262(2):243-52. PubMed ID: 6839155 [TBL] [Abstract][Full Text] [Related]
5. Effects of increasing brain GABA on the meal patterns of genetically obese vs. lean Zucker rats. Coscina DV; Castonguay TW; Stern JS Int J Obes Relat Metab Disord; 1992 Jun; 16(6):425-33. PubMed ID: 1322868 [TBL] [Abstract][Full Text] [Related]
6. Effects of lateral hypothalamic lesions on the anorexia induced by ethanolamine-O-sulfate. Coscina DV; Nobrega JN Pharmacol Biochem Behav; 1989 Jan; 32(1):275-81. PubMed ID: 2734338 [TBL] [Abstract][Full Text] [Related]
7. Evidence of a role for GABA in benzodiazepine effects on food preference in rats. Hodges HM; Green SE Psychopharmacology (Berl); 1981; 75(3):305-10. PubMed ID: 6798622 [TBL] [Abstract][Full Text] [Related]
8. Adaptation of the GABAA-receptor complex in rat brain during chronic elevation of GABA by ethanolamine O-sulphate. Lindgren S; Simmonds MA Br J Pharmacol; 1987 Jul; 91(3):617-25. PubMed ID: 3038247 [TBL] [Abstract][Full Text] [Related]
9. Chronic administration of the GABA-transaminase inhibitor ethanolamine O-sulphate leads to up-regulation of GABA binding sites. Sykes C; Prestwich S; Horton R Biochem Pharmacol; 1984 Feb; 33(3):387-93. PubMed ID: 6322803 [TBL] [Abstract][Full Text] [Related]
10. Effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl GABA and ethanolamine O-sulphate on the in vitro GABA release from rat hippocampus. Qume M; Fowler LJ Br J Pharmacol; 1997 Oct; 122(3):539-45. PubMed ID: 9351512 [TBL] [Abstract][Full Text] [Related]
11. Effect of 2-aminoethanol on the synthesis, binding, uptake and metabolism of GABA. Löscher W Neurosci Lett; 1983 Dec; 42(3):293-7. PubMed ID: 6320073 [TBL] [Abstract][Full Text] [Related]
12. A regional study of 4-aminobutyrate metabolism and amino acid levels in rat brain following chronic oral administration of ethanolamine O-sulphate. Fletcher A; Fowler LJ J Neurochem; 1982 Apr; 38(4):1022-8. PubMed ID: 7062027 [TBL] [Abstract][Full Text] [Related]
14. A novel inhibitor of gamma-aminobutyrate aminotransferase with anorectic activity. White HL; Howard JL; Cooper BR; Soroko FE; McDermed JD; Ingold KJ; Maxwell RA J Neurochem; 1982 Jul; 39(1):271-3. PubMed ID: 7086415 [TBL] [Abstract][Full Text] [Related]
15. Effects of chronic oral treatment with GABA-transaminase inhibitors on the GABA system in brain, liver, kidney, and plasma of the rat. Qume M; Fowler LJ Biochem Pharmacol; 1996 Nov; 52(9):1355-63. PubMed ID: 8937445 [TBL] [Abstract][Full Text] [Related]
16. Anorexic effects of ethanolamine-O-sulfate and muscimol in the rat: evidence that GABA inhibits ingestive behavior. Cooper BR; Howard JL; White HL; Soroko F; Ingold K; Maxwell RA Life Sci; 1980 Jun; 26(23):1997-2002. PubMed ID: 7401912 [No Abstract] [Full Text] [Related]
17. The effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl-GABA and ethanolamine-O-sulphate on the in vivo release of GABA from rat hippocampus. Qume M; Whitton PS; Fowler LJ J Neurochem; 1995 May; 64(5):2256-61. PubMed ID: 7722510 [TBL] [Abstract][Full Text] [Related]
18. The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo. Jung MJ; Lippert B; Metcalf BW; Schechter PJ; Böhlen P; Sjoerdsma A J Neurochem; 1977 Apr; 28(4):717-23. PubMed ID: 894280 [No Abstract] [Full Text] [Related]
19. Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a reevaluation of aminooxyacetic acid. Löscher W; Hönack D; Gramer M J Neurochem; 1989 Dec; 53(6):1737-50. PubMed ID: 2809589 [TBL] [Abstract][Full Text] [Related]
20. Development of the gamma-aminobutyric acid neurotransmitter system in the rat cerebral cortex during repeated administration of the GABA-transaminase inhibitor ethanolamine O-sulphate. Sykes CC; Horton RW J Neurochem; 1986 Jan; 46(1):213-7. PubMed ID: 3940282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]